Here are the stocks added to the Zacks #5 Rank ("strong sell") List today:

1-800-FLOWERS.COM Inc (FLWS) 3D Systems Corp (TDSC) ACI Worldwide Inc (ACIW) Advanta Corp (ADVNB) Alon USA Energy Inc (ALJ) Alphatec Holdings Inc (ATEC) American Water Works Co Inc (AWK) AMETEK Inc (AME) Anaren Inc (ANEN) Animal Health International Inc (AHII) Apogee Enterprises Inc (APOG) Bankrate Inc (RATE) Banner Corp (BANR) Bel Fuse Inc (BELFB) Belden Inc (BDC) Bio-Rad Laboratories Inc (BIO) Blockbuster Inc (BBI) ...

Here are the stocks added to the Zacks #5 Rank ("strong sell") List today:

Animal Health International Inc (AHII) Answers Corp (ANSW) AvalonBay Communities Inc (AVB) Ducommun Inc (DCO) Dun & Bradstreet Corp (DNB) Enzon Pharmaceuticals Inc (ENZN) EZCORP Inc (EZPW) Genesee & Wyoming Inc (GWR) Granite Construction Inc (GVA) Hornbeck Offshore Services Inc (HOS) HQ Sustainable Maritime Industries Inc (HQS) Huron Consulting Group (HURN) James River Coal Co (JRCC) King Pharmaceuticals Inc (KG) LaBranche & Co Inc (LAB) Legacy Bancorp Inc (LEGC) ...

Here are the stocks added to the Zacks #5 Rank ("strong sell") List today:

Animal Health International Inc (AHII) Benihana Inc (BNHNA) BT Group Plc (BT) Carnival Plc (CUK) Cummins Inc (CMI) Delta Natural Gas Company Inc (DGAS) Dover Motorsports Inc (DVD) Eagle Materials Inc (EXP) Entertainment Properties Trust (EPR) Esterline Technologies Corp (ESL) First Advantage Corp (FADV) First State Bancorp NM (FSNM) FirstEnergy Corp (FE) FirstService Corp (FSRV) Gerber Scientific Inc (GRB) GlobalOptions Group Inc (GLOI) HEICO Corp (HEI) ING Groep NV (ING) Limco-Piedmont Inc (LIMC) Lodgian Inc (LGN) Mack-Cali Realty Corp (CLI) Nalco Holding Co (NLC) National Retail Properties Inc (NNN) Pitney Bowes Inc (PBI) Prospect Capital Corp (PSEC) Pulte Homes Inc (PHM) RBC Bearings Inc (ROLL) Republic Airways Holdings ...

Animal Health International, Inc. (AHII) reported lower-than-expected fourth-quarter net income of $2.7M, or EPS of $0.11. Nonetheless, EBITDA increased 27.2% year-over-year after adjusting for a one-time charge in the comparable quarter last year, and was driven primarily by an increase in sales volume.

We are encouraged by the expansion of gross profit margins and continue to believe the company is well positioned to take advantage of currently challenging economic conditions to grow its production animal business via acquisition. We retain our Buy recommendation at current levels.

With a significant number of products expected to lose patent protection over the next several years, we believe the company is well positioned to enhance margin expansion through the incremental addition of private label products to the product mix. We have valued AHII on a forward price/earnings basis, as well as a comparison to similar firms in the animal health products sector. Our $9

...

Animal Health International, Inc. (NASD: AHII), through its wholly owned subsidiaries, is engaged in the distribution of animal health products in the United States and Canada. The company’s management team recently commented on its fiscal year 2008 financial results and outlook for 2009. Shares of Animal Health International declined earlier this week after the announcement of net income of $2.7 million, or $0.11 per fully diluted share. Analysts had predicted net income of $0.13 per share.

Net sales increased 11.7 percent, or $18.6 million, to $178.3 million for the three months ended June 30, 2008, up from $159.7 million during the same quarter last year. For the fiscal year, net sales increased by 13.8 percent to $87 million for the year ended June 30, 2008. Acquisitions accounted for 69 percent, or $60.2 million, of the annual increase and organic sales gained 4.3 percent from the same period last year.

The CFO

...

With a significant number of products expected to lose patent protection over the next several years, we believe Animal Health International, Inc. (AHII) is well positioned to enhance margin expansion through the incremental addition of private label products to the product mix.

Animal HealthÂ’s existing infrastructure and longstanding supplier relationships on the production side represent significant comparative advantages, which underpin the companyÂ’s ability to grow both organically and via acquisition in both the production animal and relatively faster growing companion animal markets. In addition to its branded product offering, the company also distributes its own higher margin private label product lines, which are marketed under the RXV Products, AGRIpharm, First Companion, Mineral Max, and Ivermax brands.

The company is expected to report fourth-quarter financial results on September 18. Our current revenue and EPS estimates are $181 million and $0.17 respectively versus consensus estimates of $176 million and $0.14. Our

...